Metraipolis › archive › dc_960b03547d2e

Repression of EGFR by new biguanide 4C potentiated ovarian cancer to PARP inhibitors through down-regulation of BRCA2 and Rad51 — Europe PMC PMID:41851090

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41851090
DOI: 10.1038/s41419-[numero omesso]-w
License (as archived): solo-consultazione
Archived: 2026-11-04T06:16:36.913Z
SHA-256 of the archived text: e505b385dc8a6ee7cb79136a756f694160271ff174e6f0e685ba7baa76f3be86
Stable URL of this page: https://metraipolis.com/documento/dc_960b03547d2e

How to cite

Repression of EGFR by new biguanide 4C potentiated ovarian cancer to PARP inhibitors through down-regulation of BRCA2 and Rad51 — Europe PMC PMID:41851090 — Europe PMC (en), https://europepmc.org/article/MED/41851090 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_960b03547d2e (Metraipolis archive dc_960b03547d2e, sha256 e505b385dc8a6ee7cb79136a756f694160271ff174e6f0e685ba7baa76f3be86)

BibTeX

@misc{dc960b03547d2e,
  title = {Repression of EGFR by new biguanide 4C potentiated ovarian cancer to PARP inhibitors through down-regulation of BRCA2 and Rad51 — Europe PMC PMID:41851090},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41851090},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_960b03547d2e; sha256 e505b385dc8a6ee7cb79136a756f694160271ff174e6f0e685ba7baa76f3be86},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41851090. Agents can read the archived copy with the MCP tool read_document.